RightFit
RecruitingNot applicable

Dietary Peanuts and Nutrition-Related Outcomes

Dietary Peanut Intake and Nutrition-Related Outcomes in Individuals Using GLP-1 Receptor Agonists: A Randomized Controlled Trial

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 80 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests how eating peanuts every day for 12 weeks affects weight, diet, fullness, energy, and blood test results. It is for adults taking semaglutide or tirzepatide who meet the study’s weight and health rules. The text lists different medicine-use times—3 months and 6 months—so this needs to be checked with the study team.

This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding peanuts to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating peanuts improves overall diet quality and health markers like tiredness and certain levels in blood.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health problem. BMI is a measure based on height and weight.
  • Use semaglutide or tirzepatide for a medical reason or have used it for at least 6 months, as stated in the eligibility rules.

Who can't join

  • Do not use a GLP-1 medicine, such as semaglutide or tirzepatide, or have a medical reason that makes it unsafe to use.
  • Have a known nut allergy.
  • Are pregnant or breastfeeding.
  • Are in jail or prison.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weight-related comorbidity who have been using semaglutide or tirzepatide for a clinical indication or at least 6 months Exclusion Criteria: * No use or contraindication to use of a GLP-1 RA * Known allergy to nuts * Pregnant or breastfeeding * Incarcerated

Study sites (1)

OH